Delivery Order SPE2DB20D2104-SPE2DB25FNBFB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,106.38 to AmerisourceBergen Drug Corp for COSOPT PF Eye Drops (15 count) under a firm fixed-price contract. This non-set-aside award was issued on July 8, 2025, with an ultimate completion date of July 9, 2025. The products will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award is for the delivery of COSOPT EYE DROPS 10ML to the Defense Logistics Agency. The $1,144.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 11, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract that Amerisourcebergen holds with the Defense Logistics Agency Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,530.51, is a Firm Fixed Price Delivery Order for the supply of COSOPT PF EYE DROPS 15S. The contract has an ultimate completion date of June 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,998.97 firm fixed price delivery order covers the supply of COSOPT PF eye drops for a period ending on January 24, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distribution company, for the provision of Cosopt eye drops. The contract is a Delivery Order valued at $2,965.60, with a firm fixed price and an ultimate completion date of April 17, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,576.43, is for the delivery of COSOPT PF Eye Drops 15S, a pharmaceutical product. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) with Cencora, Inc., doing business as Amerisourcebergen, valued at up to $999,999,999.00. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,726.34, is for the delivery of COSOPT EYE DROPS 10ML. This is a firm fixed-price delivery order contract with an ultimate completion date of December 19, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of COSOPT EYE DROPS 10ML to the Defense Logistics Agency (DLA). The Firm Fixed Price contract has a ceiling value of $3,172.50 and an ultimate completion date of April 18, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at $999,999,999. The contract, which is not set aside, covers a wide range of essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits to support military healthcare programs globally. The current delivery...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of COSOPT PF eye drops. The $1,349.20 firm fixed-price contract has a completion date of September 13, 2023. This contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBFBDelivery Order
This delivery order, awarded on September 23, 2025, provides COSOPT PF eye drops (15-unit quantity) to the Defense Logistics Agency (DLA) with a ceiling value of $1,312.86 under firm fixed price terms. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with no set-aside designation applied. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp functions as a critical vendor for federal medical procurement, supplying a broad portfolio of pharmaceutical products and medical supplies to support Department of Defense and veteran healthcare systems. The company's extensive federal contract history demonstrates its capability to fulfill competitive awards across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies. The DLA, as the funding agency, manages pharmaceutical procurement across military health systems globally, and AmerisourceBergen's prime vendor status enables the company to deliver essential medical commodities efficiently to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/23/25 |